Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04903197
Title Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | DEU | AUS

Facility Status City State Zip Country Details
Novartis Investigative Site Melbourne Victoria 3004 Australia Details
Novartis Investigative Site Shanghai 200032 China Details
Novartis Investigative Site Tianjin 300020 China Details
Novartis Investigative Site Leipzig 04103 Germany Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Yamagata 990 9585 Japan Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Seoul 05505 Korea, Republic of Details
Novartis Investigative Site Singapore 119228 Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field